A multiscale model reveals how ERK/p38-regulated dormancy shapes tumor-immune dynamics and immunoediting outcomes - Quiz - MDSpire

A multiscale model reveals how ERK/p38-regulated dormancy shapes tumor-immune dynamics and immunoediting outcomes

  • By

  • Eti Nyamekeh Baffoe

  • Anass Bouchnita

  • July 3, 2026

  • 0 min

Share

Original Source(s)

A multiscale model reveals how ERK/p38-regulated dormancy shapes tumor-immune dynamics and immunoediting outcomes

  • by Eti Nyamekeh Baffoe, Anass Bouchnita

  • July 3, 2026

Related Content

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study